0001415889-16-006163.txt : 20160610 0001415889-16-006163.hdr.sgml : 20160610 20160610184700 ACCESSION NUMBER: 0001415889-16-006163 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160610 FILED AS OF DATE: 20160610 DATE AS OF CHANGE: 20160610 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daly James M CENTRAL INDEX KEY: 0001560782 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 161709541 MAIL ADDRESS: STREET 1: INCYTE CORPORATION EXPERIMENTAL STATION STREET 2: RTE 141 & HENRY CLAY RD. BLDG E336 CITY: WILMINGTON STATE: DE ZIP: 19880 4 1 form4-06102016_030651.xml X0306 4 2016-06-10 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001560782 Daly James M 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 true false false false Stock Option (right to buy) 39.60 2016-06-10 4 A 0 12500 0 A 2026-06-09 Common Stock 12500 12500 D 25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following the date of grant. /s/ Elizabeth Carter, Attorney-in-Fact 2016-06-10